Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study

To establish the dose–response relationship for pharmacodynamics (bronchodilatation), safety and pharmacokinetics of a novel particle engineered formulation of Glycopyrronium bromide (PSX1002-GB) in patients with chronic obstructive pulmonary disease (COPD).

Gespeichert in:
Autor*in:

Singh, Dave [verfasserIn]

Ravi, Arjun

Reid, Frederick

Buck, Helen

O'Connor, Gemma

Down, Geoff

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2016

Schlagwörter:

Glycopyrronium bromide

Long acting anti-muscarinic agent (LAMA)

Pressurised metered-dose inhaler (pMDI)

COPD

Umfang:

6

Übergeordnetes Werk:

Enthalten in: Are only the strong surviving? Little influence of restoration on beetles (Coleoptera) in an agricultural landscape - Jellinek, Sacha ELSEVIER, 2013, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:37 ; year:2016 ; pages:9-14 ; extent:6

Links:

Volltext

DOI / URN:

10.1016/j.pupt.2016.01.003

Katalog-ID:

ELV040181065

Nicht das Richtige dabei?

Schreiben Sie uns!